Akuru Pharma AB was recently granted “Acceleratorstöd” from Innovationskontor Syd for development of novel diagnostic tools for kidney cancer.
Akuru Pharma AB was recently granted “Acceleratorstöd” from Innovationskontor Syd for development of novel diagnostic tools for kidney cancer.